Company & Sponsor Intelligence
University of Arizona
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting1
Completed4
Countries1
Therapeutic footprint
adhddementia_otherdepressionout_of_scopeparkinsons
Indexed studies
NCT03652012Probing Cortical Excitability and Cognitive Function With TMS
dementia_other · United StatesNA
dementia_other · United StatesNA
NCT02556164Electro-acupuncture for Gait and Balance in Parkinson's Disease
parkinsons · NA
parkinsons · NA
NCT00517972Omacor for Perimenopausal Depression
depression · United StatesPHASE2
depression · United StatesPHASE2
NCT03685279Efficacy of the Nurtured Heart Approach to Reduce ADHD Behaviors in Children
adhd · United StatesNA
adhd · United StatesNA
NCT00517647Atomoxetine Pilot Study in Preschool Children With ADHD
adhd · United StatesPHASE4
adhd · United StatesPHASE4
NCT07564960Social Optimization Study
out_of_scope · United StatesNA
out_of_scope · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →